Prestige Consumer Healthcare Inc

PBH | Healthcare | NYSE
$59.83
-0.70 (-1.16%)

Key Metrics

Market Cap
$2.94B
P/E Ratio
14.04
EPS
$4.26
Beta
N/A
Dividend Yield
N/A
ROE
11.82%
Current Ratio
4.38

Company Information

Industry
Medical Distribution

About Prestige Consumer Healthcare Inc

Prestige Consumer Healthcare Inc together with its subsidiaries develops manufactures markets distributes and sells overthecounter OTC health and personal care products in the United States and internationally The company operates in two segments North American OTC Healthcare and International OTC Healthcare It offers BCGoodys analgesic powders Boudreauxs Butt Paste baby ointments Chloraseptic sore throat liquids and lozenges Clear Eyes for eye redness relief Compound W wart removals DenTek for PEG oral care Debrox ear wax removals and Dramamine for motion sickness relief The company also provides Fleet adult enemassuppositories Gaviscon upset stomach remedies Ludens cough drops Monistat vaginal antifungal Nix liceparasite treatments Summers Eve feminine hygiene TheraTears dry eye relief Fess nasal saline spray and washes and Hydralyte for oral rehydration products It sells its products through mass merchandisers and drug food dollar convenience and club stores as well as ecommerce channels The company was formerly known as Prestige Brands Holdings Inc and changed its name to Prestige Consumer Healthcare Inc in August 2018 Prestige Consumer Healthcare Inc was founded in 1996 and is headquartered in Tarrytown New York

Recent Earnings Surprises

Date Actual EPS Estimated EPS Surprise
2025-08-07 $0.95 $1.01 -5.9%
2025-05-08 $1.32 $1.30 +1.5%
2025-02-06 $1.22 $1.16 +5.2%
2024-11-07 $1.09 $1.08 +0.9%

Financial Ratios (TTM)

Gross Margin
56.18%
Operating Margin
30.04%
Net Margin
19.02%
ROA
6.21%
Price to Book
1.61
Price to Sales
2.66